期刊文献+

口服固体制剂原辅料相容性研究进展 被引量:19

Progress of Drug-excipients Compatibility in Oral Solid Dosage Forms
原文传递
导出
摘要 对近年来国内外在原辅料相容性方面的研究进行综述,以便于制剂工作者更好地进行处方设计。笔者首先分析了口服固体制剂原辅料发生不相容的原因,随后对各种原辅料相互作用进行了深入的阐述,并列举了近年来研究的成果;随后对影响原辅料相互作用的外界因素进行了分析和列举;最后对近年来采用的原辅料相容性研究手段进行了综述,为今后更好地开展此类研究提供参考。 To summarize the recently researches of drug-excipients compatibility, in order to help the pharmaceutical dosage formula design. The reasons of the incompatibility of drug-excipients in oral solid dosage forms were analysed at first, then the interactions of drug-excipients were disscused deeply, some research achievements were examplized. The extra-factors which influence the drug-excipients compatibility were disccused. The advanced research methods were summarized to help researches in this field.
作者 胡士高 孙备
出处 《中国现代应用药学》 CAS CSCD 2012年第9期789-793,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 相容性 研究进展 原辅料 口服固体制剂 compatibility progress drug-excipients oral solid dosage forms
  • 相关文献

参考文献19

  • 1Q8(R2), ICH Guidelines [S]. 2009.
  • 2SCHMITT A E, PECK K, SUN Y, et al. Rapid, practical and predictive excipients compatibility screening using isothermal microcalorimetry [J]. Thermochimica Acta, 2001, 380: 175-184.
  • 3MASUDA T, YOSHIHASHI Y, YONEMOCHI E, et al. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir [J]. Int J Pharm, 2012, 422(1): 160-169.
  • 4RICHARDS R M, X1NG J Z, MACKAY K M. Excipients interaction with cetylpyridinium chloride activity in tablet based lozenges [J]. Pharm Res, 1996, 13(8): 1258-1264.
  • 5COTTON M L, WU D W, VADAS E B. Drug-excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy [J]. Int J Pharm, 1987, 40(1): 129-142.
  • 6NIEUWMEYER F, VAN DER VOORT MAARSCHALK K, VROMANS H. Lactose contaminant as steroid degradation enhancer [J]. Pharm Res, 2008, 25(11): 2666-2673.
  • 7QIU Y H, CHEN Y S, ZHANG G Z, et al. Developing Solid Oral Dosage Form: Pharmaceutical Theory & Practice [M]. 1 st ed. Waltham: Academic Press, 2009: 125-145.
  • 8MIHRANYAN A, STROMME M, EK R. Influence of cellulose powder structure on moisture-induced degradation of acetylsalicylic acid [J]. Eur J Pharm Sci, 2006, 27(2): 220-225.
  • 9DESAI D S, RUBITSKI B A, VARIA S A, et al. Povidone- and poloxamer-mediated degradation of hydrochlorothiazide in an antihypertensive combination tablet product [J]. Int J Pharm, 1996, 142(1): 61-66.
  • 10CHENG W T, WANG S L, LIN S Y. Effect of moistrue content on solid-state interaction at the interface between magnesium stearate and captopril [J]. Appl Surface Sci, 2008, 225(5): 2782-2786.

二级参考文献7

  • 1Li Wei GUO Yuan Jing XIAO Li Ping YANG.A New Route for Synthesis of Entecavir[J].Chinese Chemical Letters,2006,17(7):907-910. 被引量:4
  • 2SHERMAN M, YURDAYDIN C, SOLLANO J. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B[J]. Gastroenterology, 2006, 130(7): 2039-2049.
  • 3FABIEN ZOULIM F. Entecavir: A new treatment option for chronic hepatitis B[J]. J Clin Virol, 2006, 36(1): 8-12.
  • 4YU H W, LI J, MENG Q H, et al. Clinical study of entecavir treatment in patients with subacute on chronic liver failure[J]. J Clin Hepatol, 2008, 11(6):380-382.
  • 5庄越 曹宝成 萧瑞祥.实用药物制剂技术[M].北京:人民卫生出版社,2002.4-20.
  • 6陈新谦,金有豫,汤光.新编药物学[M].第15版.北京:人民卫生出版社,2004:716-717.
  • 7李莉,周延安.3种药物治疗慢性乙型肝炎的成本-效果分析[J].药物流行病学杂志,2008,17(5):340-341. 被引量:5

共引文献17

同被引文献128

引证文献19

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部